TomTec Imaging Systems GmbH of Germany's senior management has been ableto acquire outstanding shares held by Kretztechnik AG of Austria. TomTec is a global provider in the area of 2D-, 3D- and 4D-solutions for medical ultrasound.
After a management buyout in 1997, TomTec decided to take on Kretztechnik as a shareholder for its board. At the beginning of the collaboration, Kretztechnik held 33.33% of TomTec's shares although, as of early 2000, all but 7.2% of Kretztechnik's shares were sold to ABN AMRO Ventures of the Netherlands. After GE Medical Systems acquired Kretztechnik, TomTec was put into a competitive scenario. At this point, the company explains, TomTec's senior management started to negotiate the acquisition of the outstanding shares and has now successfully completed these transactions.
"With this acquisition, the four active shareholders - Holger Frank, Bernhard Mumm, Frank Schlau and Ulrich Haupt - set an example and place another milestone in further developing TomTec's leading role as a global player. With this transition completed, the TomTec senior management has possession of 44.31% of the shares and TomTec employees hold 2.14% shares," stated the firm's chief executive, Ulrich Haupt.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze